For mass lesions, combining qualitative features like intratumoral T2 hyperintensity and mass shape allowed for effective discrimination between HER2-low and HER2-zero breast cancers, with an AUC of 0.763. The gene discussed is ERBB2; the disease is breast carcinoma.